Safety Information

KEYTRUDA® (pembrolizumab) Pooled Safety

UK Prescribing Information can be found here. [External link]

Always refer to the full Summary of Product Characteristics before prescribing for up-to-date and complete safety considerations to help minimise the risks associated with the use of KEYTRUDA.

KEYTRUDA Summary of Product Characteristics [External link]

Supporting documentation

UK Prescribing Information can be found here. [External link]
By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website.

GB-PDO-03437 | Date of Preparation: February 2025